🔍

IONEXCHANG - ION Exchange

📊 NSE: IONEXCHANG 🏢 Engineering - Turnkey Services 📅 Last Updated: 12/14/2025 8:25

📢 Recent Corporate Announcements

ION Exchange: ACETP Appeals Dismissal of INR 17.48 Crore Claim in Madras High Court

🔵 WATCH ⭐ 4/10

LEGAL 📅 06 Mar 2026, 03:03 PM

ION Exchange (India) Limited has been notified of an appeal filed by Angeripalayam Common Effluent Treatment Plant Limited (ACETP) in the Madras High Court. ACETP is challenging a previous Arbitral Award that had dismissed its claims against ION Exchange. The claims in question amount to INR 17.48 crores plus accrued interest. This development extends a long-standing legal dispute that the company previously reported in 2023 and early 2026.

ACETP is appealing to set aside an Arbitral Award that favored ION Exchange.
The disputed claim involves a principal amount of INR 17.48 crores plus interest.
The appeal has been filed before the Commercial Division of the Hon’ble High Court of Judicature at Madras.
This follows a previous dismissal of the claims by a Sole Arbitrator.

💡 Monitor the progress of the High Court appeal; while the initial dismissal is positive, the potential liability of INR 17.48 crore remains a contingent risk.

Ion Exchange Subsidiary Bags INR 1,730 Crore Order from Petroleum Development Oman

🟢 POSITIVE ⭐ 8/10

ROUTINE 📅 10 Feb 2026, 06:56 PM

Ion Exchange (India) Limited's Oman-based subsidiary has secured a significant long-term contract from Petroleum Development Oman (PDO). The agreement covers the Design, Build, Own, Operation, and Maintenance (DBOOM) of potable water and sewage treatment facilities in the South PDO Concession Area. Valued at approximately INR 1,730 crores (OMR 73.46 million), the contract spans a 20-year period. This win significantly enhances the company's international order book and provides long-term revenue visibility.

Total contract value of approximately INR 1,730 crores (OMR 73.46 million)
Long-term contract duration of 20 years providing steady revenue streams
Scope includes Design, Build, Own, Operation, and Maintenance (DBOOM) of water facilities
Awarded by Petroleum Development Oman to the company's Oman-based subsidiary
Strengthens the company's footprint in the Middle East water treatment market

💡 Investors should view this as a major positive development that secures long-term cash flows and validates the company's expertise in large-scale international projects. The stock may see positive momentum given the substantial order size relative to the company's annual turnover.

ION Exchange Q3 FY26: Revenue Up 6% to ₹7,344M, EBITDA Drops 21% on Roha Costs and Adverse Mix

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 09 Feb 2026, 05:35 PM

ION Exchange reported a consolidated revenue of INR 7,344 million for Q3 FY26, a 6% YoY increase, but EBITDA fell 21% to INR 593 million. Profitability was significantly impacted by an exceptional item of INR 169 million for labor code provisions and higher depreciation/interest from the newly commissioned Roha facility. Despite margin pressure, the company maintains a strong order book of INR 28,330 million, with new solar sector wins totaling INR 2,050 million. Management expects a recovery in Q4 as deferred international engineering contracts are executed.

Consolidated EBITDA margin contracted to 8.07% from 10.8% YoY due to Roha facility costs and rupee depreciation.
Engineering segment EBIT declined 28% YoY to INR 186 million, hampered by muted execution of UP Jal Nigam orders.
Chemical division revenue grew 16% YoY to INR 2,307 million, though EBIT fell 18% due to product mix and facility ramp-up.
Total order book stands at INR 28,330 million with a quarterly order inflow of INR 5,160 million.
Exceptional charge of INR 169 million recognized for employee benefits following the notification of new Labour Codes.

💡 Investors should monitor the utilization levels of the Roha facility and the execution pace of the high-margin international order book in Q4. While short-term margins are under pressure, the robust order book and alignment with government infrastructure spending provide a positive long-term outlook.

ION Exchange Releases Q3 FY 2025-26 Earnings Conference Call Audio Recording

🟡 NEUTRAL ⭐ 3/10

EARNINGS 📅 02 Feb 2026, 05:57 PM

ION Exchange (India) Limited has officially released the audio recording of its earnings conference call held on February 2, 2026. The call focused on the company's operational and financial performance for the third quarter and nine months ended December 31, 2025. This disclosure is part of the mandatory regulatory requirements under SEBI (LODR) Regulations, 2015. The recording provides institutional investors and analysts with management's detailed commentary on the quarter's results and future outlook.

Audio recording of the Q3 FY 2025-26 earnings call is now available on the company website.
The call was conducted on February 2, 2026, with various institutional investors and analysts.
Discussion covered financial performance for the nine-month period ending December 31, 2025.
Compliance filing made under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements.

💡 Investors should listen to the recording to gain insights into management's perspective on the order book and margin sustainability. No immediate trading action is required based on this procedural filing.

ION Exchange Q3 FY26: Net Profit Drops 58.5% YoY to ₹20.6 Cr Despite 6.4% Revenue Growth

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 02 Feb 2026, 11:52 AM

ION Exchange reported a weak Q3 FY26 with consolidated revenue growing 6.4% YoY to ₹734.4 crore, but PAT plummeted 58.5% to ₹20.6 crore. Profitability was severely impacted by a sharp contraction in EBITDA margins, which fell to 8.07% from 10.92% YoY, and a ₹16.9 crore exceptional item. The engineering segment faced headwinds from deferred international dispatches and muted execution of the UP Jal Nigam order, although the bid pipeline remains strong at ₹9,556 crore. The chemicals segment saw revenue growth but margins were pressured by startup costs at the new Roha facility.

Consolidated Operating Income rose 6.4% YoY to ₹7,344 Mn, while Operating EBITDA fell 21.4% to ₹593 Mn.
Net Profit (PAT) declined 58.5% YoY to ₹206 Mn, with PAT margins shrinking from 7.18% to 2.81%.
Engineering order book stands at ₹2,833 Cr with a massive bid pipeline of ₹9,556 Cr.
Chemicals segment revenue grew to ₹2,307 Mn, but EBIT was impacted by Roha facility costs and product mix.
Deferred international engineering contracts and slow UP Jal Nigam execution significantly hampered quarterly performance.

💡 Investors should exercise caution as the company faces significant margin pressure and execution delays in its engineering segment. While the bid pipeline is robust, the immediate focus should be on the stabilization of the Roha facility and the recovery of deferred international orders in Q4.

ION Exchange Q3 Standalone PAT Drops 55% YoY to ₹24.06 Cr; Impacted by Exceptional Item

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 29 Jan 2026, 07:31 PM

ION Exchange reported a standalone revenue of ₹668.93 crore for Q3 FY26, representing a modest 3% growth compared to ₹649.93 crore in the same quarter last year. However, Profit After Tax (PAT) declined sharply by 55% YoY to ₹24.06 crore, down from ₹53.33 crore in Q3 FY25. This decline was significantly impacted by a one-time exceptional charge of ₹14.54 crore related to the implementation of new Labour Codes. Operating margins were also pressured by a 23% YoY increase in employee benefit expenses and higher finance costs.

Standalone Revenue from operations grew 3% YoY to ₹668.93 crore but declined slightly on a QoQ basis.
Standalone PAT fell 55% YoY to ₹24.06 crore, with Basic EPS dropping from ₹4.34 to ₹1.96.
Recognized a one-time exceptional item of ₹14.54 crore due to increased gratuity and leave liabilities from new Labour Codes.
Total expenses rose to ₹636.51 crore from ₹587.76 crore in the previous year's quarter, driven by higher employee costs and depreciation.
Profit before tax (excluding exceptional items) stood at ₹46.67 crore, still significantly lower than the ₹72.93 crore reported in Q3 FY25.

💡 Investors should exercise caution as the sharp drop in profitability and rising operating expenses suggest margin pressure. It is important to monitor if the company can pass on these increased costs to customers in future quarters.

ION Exchange to Host Q3 & 9M FY26 Earnings Conference Call on February 2, 2026

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 27 Jan 2026, 05:59 PM

ION Exchange (India) Limited has scheduled a conference call with institutional investors and analysts on February 2, 2026, at 2:00 PM IST. The purpose of the call is to discuss the company's financial performance for the third quarter and the nine-month period ending December 31, 2025. The session will feature top management, including the Vice Chairman, Managing Director & CEO, and Group CFO. This meeting provides a platform for stakeholders to understand the company's growth trajectory and operational efficiency during the current fiscal year.

Conference call scheduled for February 2, 2026, at 2:00 PM IST to discuss Q3 and 9M FY26 results.
Management representation includes Vice Chairman Mr. Aankur Patni and MD & CEO Mr. Indraneel Dutt.
Universal dial-in numbers for the call are +91 22 6280 1341 and +91 22 7115 8242.
The call will cover the financial period ending December 31, 2025.

💡 Investors should attend or review the transcript of the call to gain insights into the company's order book and execution capabilities. Monitor for any updates regarding the water treatment and chemical segments' performance.

ION Exchange Wins Arbitration; ₹17.48 Crore Claim Dismissed

🟢 POSITIVE ⭐ 7/10

LEGAL 📅 12 Jan 2026, 05:41 PM

ION Exchange (India) Limited has received a favorable arbitral award regarding a long-standing dispute with Angeripalayam Common Effluent Treatment Plant Limited (ACETP). The claimant had sought ₹17.48 crores plus interest for alleged non-performance and consequential damages. The Sole Arbitrator dismissed the claim, along with the company's counter-claim, citing they were barred by the law of limitation. This outcome removes a significant contingent liability from the company's books, improving the risk profile of the balance sheet.

Arbitral award dismissed a ₹17.48 crore claim against the company plus interest.
The dispute involved alleged non-performance of an Effluent Treatment Plant for ACETP.
Both the claim and the company's counter-claim were ruled as barred by the law of limitation.
The litigation was previously disclosed as a contingent liability in the company's financial accounts.

💡 This is a positive development as it eliminates a potential financial drain and legal uncertainty. Investors should view this as a reduction in risk for the company's balance sheet and a resolution of a legacy legal matter.

ION Exchange (India) Files Routine SEBI Compliance Certificate for Q3 FY2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 06 Jan 2026, 05:32 PM

ION Exchange (India) Limited has submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025. The certificate, provided by MUFG Intime India Private Limited, confirms that share certificates received for dematerialization were processed and the names of depositories were substituted in the records. This filing is a standard administrative requirement for listed companies in India. It ensures the integrity of the shareholding records between the company and the depositories.

Compliance certificate issued for the third quarter and nine months ended December 31, 2025.
Verification conducted by Registrar and Transfer Agent MUFG Intime India Private Limited.
Confirms that securities dematerialized were reported to CDSL, NSDL, and stock exchanges.
Ensures adherence to Regulation 74(5) of SEBI (Depositories and Participants) Regulations.

💡 This is a routine regulatory disclosure with no impact on business fundamentals. No action is required from investors based on this specific announcement.

ION Exchange Announces Trading Window Closure from January 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 26 Dec 2025, 04:08 PM

ION Exchange (India) Limited has announced the closure of its trading window for all designated persons starting January 1, 2026. This is a standard regulatory requirement under SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the quarterly financial results. The closure pertains to the unaudited financial results for the quarter and nine months ending December 31, 2025. The window will reopen 48 hours after the results are officially declared to the stock exchanges.

Trading window closure effective from January 1, 2026
Closure relates to financial results for the period ending December 31, 2025
Window to remain closed until 48 hours post-result declaration
Complies with SEBI (Prohibition of Insider Trading) Regulations, 2015

💡 This is a routine regulatory filing with no direct impact on stock fundamentals. Investors should monitor for the upcoming board meeting date to assess the company's Q3 FY26 performance.

IONEXCHANG bags ₹205 Cr orders for water treatment projects

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 15 Dec 2025, 06:45 PM

ION Exchange (India) Limited has secured contracts worth approximately ₹205 crores from Rayzon Energy Private Limited and INOX Solar Limited. These contracts are for Ultra-Pure Water systems, Effluent Treatment Plants (ETP), and Zero Liquid Discharge (ZLD) systems. Rayzon Energy's contract is worth approximately ₹95 crores for their 5.1 GW PV Solar project. INOX Solar's contract amounts to approximately ₹110 crores for ultrapure water generation, wastewater treatment, and zero liquid discharge.

Secured contracts aggregating to approximately ₹205 Crores
Rayzon Energy contract is approximately ₹95 Crore
INOX Solar contract is approximately ₹110 Crore
Rayzon Energy project is for a 5.1 GW PV Solar project
Execution timeframe is 9 months and 10 months respectively

💡 This order book expansion is a positive sign. Investors should monitor the company's execution of these projects and their impact on future revenue and profitability.

IONEXCHANG to hold Analyst/Institutional Investor Group Meet on Dec 8, 2025

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 03 Dec 2025, 06:29 PM

ION Exchange (India) Limited announced a schedule for an Analyst/Institutional Investor Group meeting to be held on December 8th, 2025, at 4:00 pm via audio/video conferencing. The company has clarified that no unpublished price sensitive information (UPSI) or financial information will be shared during the meeting. This event is part of their regular investor relations activities to maintain transparency and keep investors informed. The announcement is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analyst/Institutional Investor Group meeting on December 8th, 2025 at 4.00 pm
Meeting to be held via Audio/Video conferencing
Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Nikisha Solanki, Company Secretary & Compliance Officer, contact ACS 50894

💡 Investors can monitor the discussions from the analyst meet if a summary is released. No immediate action is required, but stay informed about future company updates.

View All IONEXCHANG Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

The Engineering segment grew 16% YoY in Q2 FY26 to INR 456.2 Cr. In FY23, the Engineering segment saw a 33% YoY increase, while the Chemical segment grew 11% YoY. Overall consolidated revenue grew 9% YoY in Q2 FY26 to INR 642.9 Cr.

Geographic Revenue Split

Not disclosed in available documents, though the company highlights growth in the Gulf, Emerging Markets, and North Africa (desalination projects), while Europe faced muted demand.

Profitability Margins

Consolidated PAT margin for Q2 FY26 was 7.47%, a slight decline from the 9.8% recorded in FY23. Engineering segment EBIT margins hit an all-time low of 4.8% in Q2 FY26 due to project mix and high infrastructure investments.

EBITDA Margin

EBITDA margin stood at 9.95% in Q2 FY26, representing a 1% YoY decline in absolute EBITDA to INR 131 Cr. Operating margins for the full fiscal 2024 moderated to 11.7% from 13.3% in FY23.

Capital Expenditure

The company is executing a capital expenditure plan of over INR 250 Cr between FY23 and FY25, primarily focused on the greenfield resin manufacturing facility in Roha, Maharashtra.

Credit Rating & Borrowing

CRISIL A+/Stable for long-term and CRISIL A1 for short-term. Interest coverage ratio was strong at 24.8 times in FY23, with debt expected to remain below INR 100 Cr despite high capex.

⚙️ Operational Drivers

Raw Materials

Key raw materials include resins, membranes, and steel for engineering projects. Specific percentage of total cost for each is not disclosed.

Import Sources

Sourced from India (Roha plant) and Europe (leveraging the Mapril acquisition). The company is also licensing membrane technology from Mann+Hummel.

Key Suppliers

Mann+Hummel (technology partner for membranes); other specific raw material suppliers are not disclosed.

Capacity Expansion

Current capacity not specified in MT; however, the company is commissioning a greenfield resin plant in Roha and has recently commissioned a 40 MLD desalination plant in North Africa with 60 MLD and 40 MLD plants in progress.

Raw Material Costs

Raw material costs are impacted by supply chain surges; the company managed a surge in costs driven by Suez Canal constraints which impacted cargo movement.

Manufacturing Efficiency

The company is leveraging its 'low-cost country presence' in India to manufacture membranes for global consumption under the Mann+Hummel partnership.

Logistics & Distribution

Impacted by Suez Canal constraints; the company is leveraging local presence in Europe through Mapril to optimize regional distribution.

📈 Strategic Growth

Expected Growth Rate

12-15%

Growth Strategy

Growth will be driven by the commissioning of the Roha resin plant, expansion into the European market via the Mapril acquisition, and a technology licensing agreement with Mann+Hummel for membrane manufacturing. The company is also targeting high-growth sectors like solar and pharmaceuticals for ultra-pure water projects.

Products & Services

Ion exchange resins, water softeners, desalination plants (40-60 MLD), ultra-pure water systems for solar/pharma, and long-term Operation & Maintenance (O&M) services.

Brand Portfolio

Ion Exchange, Zero-B (implied via consumer segment leadership in softeners).

New Products/Services

New range of membranes manufactured in India via Mann+Hummel technology; expected to contribute to global consumption and expand market share in the water treatment segment.

Market Expansion

Targeting the European continent using Mapril as a springboard and consolidating positions in the Gulf and North Africa.

Market Share & Ranking

Maintains a leadership position in the domestic water softener segment.

Strategic Alliances

Technology licensing agreement with Mann+Hummel for membrane manufacturing; acquisition of Mapril in Europe.

🌍 External Factors

Industry Trends

Increasing demand for environmental infrastructure and desalination; shift toward ultra-pure water requirements in the solar and pharmaceutical manufacturing sectors.

Competitive Landscape

Operates in a highly competitive engineering segment; competes with global and domestic water treatment players.

Competitive Moat

Durable advantage through a diverse product mix and market leadership in water treatment. The chemical segment (resins) provides a high-margin (20%+) cushion against the cyclical engineering business.

Macro Economic Sensitivity

High sensitivity to industrial capex cycles; any slowdown in the Indian economy or end-user industries (Power, Steel, Fertilizers) adversely affects revenue.

Consumer Behavior

Steady demand for water softeners and home water solutions; segment recorded healthy volume growth despite a small quarterly loss of INR 2.7 Cr.

Geopolitical Risks

Suez Canal route constraints for cargo movement and potential impacts from global tariff wars (though US/Euro business currently remains unaffected).

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to pollution norms and manufacturing standards; the Roha project required specific licenses and approvals which were previously delayed by the pandemic.